Latest Contracts News

Complii FinTech Solutions reported a solid 6.6% annual increase in recurring revenue and unveiled the first stage of a major CRM overhaul, signaling a strategic push to enhance its capital raising and compliance platform.

Adslot Ltd reported steady trading for Q2 FY26, highlighting progress in its StoreFront platform roll-out and a promising new partnership with Infomo. The company also posted positive cash flow and significant cost savings.

8common Limited reported a positive EBITDA for the first half of FY26 alongside a 4% increase in SaaS revenue, supported by significant operational cost reductions and key contract renewals.

FINEOS Corporation Holdings PLC reports a robust €27.8 million cash balance at the end of 2025, maintaining its FY25 revenue guidance despite seasonal cash flow dips and currency fluctuations.

Metals X delivered near-record tin output at its Renison operation in Q4 2025, driving a doubling of EBITDA amid improved efficiencies and strong capital progress. The company also advanced its Rentails project and maintained robust cash reserves.

Epsilon Healthcare has posted a record $2.891 million in receipts for the December 2025 quarter, nearly doubling year-on-year revenue and marking a significant turnaround with its recent ASX reinstatement.

Aeeris Ltd has reported a profitable second quarter for FY26, with total unadjusted revenue rising 61% year-on-year to $1.54 million and annual recurring revenue climbing 16.5% to nearly $4 million. The company’s operational advances and disciplined cost control underpin a promising path to sustainable profitability.

Simble Solutions reported steady cash flow and operational growth in Q4 FY25, alongside a strategic acquisition and capital raise to bolster its energy intelligence offerings.

Stakk Limited has surged to an $8.53 million annual recurring revenue run-rate in 2025, propelled by its acquisition of Radical DBX and strong SaaS growth. The fintech’s strategic moves position it for breakeven and further expansion in 2026.

Element 25 Limited has made significant strides in advancing its Butcherbird Expansion Project in Western Australia, securing $60 million in funding and progressing key engineering and contract milestones. Simultaneously, the company moves closer to finalising financing for its US-based battery-grade manganese refinery.

Chimeric Therapeutics reports encouraging clinical progress in its CAR-T and NK cell therapy trials, alongside FDA orphan drug designation and a strategic funding boost to propel development.

Meteoric Resources has cleared a major regulatory hurdle with the approval of its Preliminary Environmental License for the Caldeira Rare Earths Project, enabling the company to progress towards construction and first production targeted for 2028. The company also commissioned its pilot plant, producing its first batches of rare earth carbonate.